PDL BioPharma Inc. (PDLI) announced revenue guidance for its fourth quarter. The company expects revenue of approximately $57 million compared to $69 million for the fourth quarter of 2008.
Analysts polled by Thomson Reuters expect the company to report revenue of $60.61 million for the quarter.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.